Gettysburg, PA, Oct. 01, 2017 -- Effective population health management is crucial for health care providers’ future business sustainability. The movement from fee-for-service to value-based service models requires providers to identify and track patients within a larger population. Moreover, providers are increasingly compelled to report on performance measures for the specific population and receive payments based on the performance. Therefore, providers must alter their current workflows and rely on a new set of skills and activities to survive in this emerging service delivery paradigm.
Join Relias to hear from Carol Clayton, PhD, former CEO of CMT, a data analytics solution company, and Tammy Floyd, LPN/Healthcare Home Director of North Central Missouri Mental Health Center, as they talk about their journey together in supporting the evolution of the behavioral health provider system to fully functioning population health homes in the state of Missouri.
During this 60- minute executive briefing, attendees will hear:
- A framework for population health management – objectives, functionality, technology, and training
- Strategies for selecting and reporting on performance measures
- How they made population health management work at the Missouri Coalition For Behavioral Health
To learn more about this executive web briefing, or take advantage of free online registration, please visit: https://www.openminds.com/event/key-improving-population-health-management/.
All registrants will receive (at no charge and regardless of attendance) a recording of the webinar and an electronic copy of the presentation slides at its conclusion.
* * *
ABOUT Relias Learning Company
Relias Learning offers online training to post-acute care, acute care, health and human services, autism and applied behavior analysis, public safety, payers, schools, and intellectual and developmental disabilities organizations. It’s our mission to measurably improve the lives of the most vulnerable members of society and those who care for them.
ABOUT OPEN MINDS
OPEN MINDS is an award-winning information source, executive education provider, and business solutions firm specializing in the post-acute health and human service markets. For thirty years, we’ve been pioneers for change – helping organizations implement the transformational business practices they need to succeed in an evolving market with new policies and regulations.
OPEN MINDS is powered by a national team of experienced executives and subject matter experts with specific expertise in the post-acute health care market. Our mission is to improve the quality of care for individuals with complex support needs by improving the effectiveness of those serving them – provider organizations, payer and insurance organizations, government agencies, pharmaceutical organizations, and technology firms. Learn more at www.openminds.com.
OPEN MINDS Executive Education Events Team OPEN MINDS 7173341329 [email protected]


Instagram Outage Disrupts Thousands of U.S. Users
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 



